IHE Holdings
iShares U.S. Pharmaceuticals ETF
1W: +1.8%
1M: +6.1%
3M: +4.9%
YTD: +25.6%
1Y: +44.6%
3Y: +90.9%
5Y: +85.2%
Error: Binder Error: Contents of view were altered: types don't match! Expected [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, VARCHAR], but found [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, BIGINT, VARCHAR] instead
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$1.2B
Holdings53
Top 10 Wt80.4%
Beta0.48
% Profitable41%
Coverage99%
Portfolio Valuation
P/E44.2
P/B13.3
P/S9.5
EV/EBITDA27.2
P/FCF44.0
PEG1.93
Profitability & Returns
Gross Margin69.8%
Net Margin21.3%
ROE32.5%
ROA11.7%
ROIC25.1%
Div Yield1.47%
Leverage & Liquidity
Debt/Equity0.73
Debt/Assets0.27
Net Debt/EBITDA1.1x
Interest Cov21.4x
Current Ratio1.24
Quick Ratio0.91
Growth (YoY)
Revenue+22.8%
Net Income+14.7%
EPS+16.0%
FCF+38.1%
EBITDA+26.6%
Rev CAGR 3Y+20.8%
Quality Scores
Piotroski F6.1
Altman Z8.39
IS Quality72.1
IS Overall61.1
IS Value42.4
Median P/E-0.1
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 53 | 99.9% | 4.5 |
| Other | 3 | 0.1% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 56 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY | LLY | 25.28% | $392.2M | 305,926 | 44.4 | $1.3T | Healthcare |
| 2 | JOHNSON & JOHNSON | JNJ | 22.31% | $346.1M | 1,287,750 | 41.7 | $662.5B | Healthcare |
| 3 | ROYALTY PHARMA PLC CLASS A | RPRX | 4.78% | $74.1M | 1,135,281 | 27.4 | $29.4B | Healthcare |
| 4 | PFIZER | PFE | 4.76% | $73.8M | 2,476,099 | 39.6 | $170.7B | Healthcare |
| 5 | ZOETIS INC CLASS A | ZTS | 4.73% | $73.4M | 938,284 | 13.0 | $32.6B | Healthcare |
| 6 | VIATRIS | VTRS | 4.67% | $72.4M | 3,869,062 | -53.3 | $22.1B | Healthcare |
| 7 | MERCK & CO INC | MRK | 4.26% | $66.1M | 466,257 | 116.1 | $361.0B | Healthcare |
| 8 | BRISTOL MYERS SQUIBB | BMY | 4.24% | $65.7M | 1,067,939 | 13.6 | $125.4B | Healthcare |
| 9 | JAZZ PHARMACEUTICALS PLC | JAZZ | 2.91% | $45.2M | 218,665 | 13.7 | $13.5B | Healthcare |
| 10 | ELANCO ANIMAL HEALTH | ELAN | 2.46% | $38.1M | 1,682,992 | -56.7 | $11.6B | Healthcare |
| 11 | CORCEPT THERAPEUTICS | CORT | 1.81% | $28.1M | 320,439 | 165.3 | $9.3B | Healthcare |
| 12 | AXSOME THERAPEUTICS | AXSM | 1.37% | $21.3M | 149,978 | -38.3 | $7.5B | Healthcare |
| 13 | LIGAND PHARMACEUTICALS | LGND | 1.35% | $20.9M | 67,151 | 122.5 | $6.3B | Healthcare |
| 14 | DEFINIUM THERAPEUTICS INC | DFTX | 1.08% | $16.8M | 452,613 | -11.0 | $5.1B | Healthcare |
| 15 | VERADERMICS | MANE | 0.96% | $14.9M | 105,549 | — | $6.0B | Healthcare |
| 16 | INDIVIOR PHARMACEUTICALS INC | INDV | 0.89% | $13.8M | 397,537 | 9.6 | $4.4B | Healthcare |
| 17 | AMNEAL PHARMACEUTICALS INC CLASS A | AMRX | 0.86% | $13.3M | 621,814 | 42.9 | $6.8B | Healthcare |
| 18 | ORGANON | OGN | 0.78% | $12.2M | 884,599 | 17.5 | $3.6B | Healthcare |
| 19 | LIQUIDIA | LQDA | 0.73% | $11.4M | 250,261 | 28.7 | $4.0B | Healthcare |
| 20 | EDGEWISE THERAPEUTICS | EWTX | 0.70% | $10.8M | 274,366 | -21.0 | $4.2B | Healthcare |
| 21 | AMYLYX PHARMACEUTICALS | AMLX | 0.63% | $9.8M | 346,682 | -20.3 | $3.6B | Healthcare |
| 22 | ENLIVEN THERAPEUTICS | ELVN | 0.60% | $9.4M | 214,724 | -27.5 | $3.3B | Healthcare |
| 23 | TARSUS PHARMACEUTICALS | TARS | 0.59% | $9.2M | 130,073 | -68.1 | $3.5B | Healthcare |
| 24 | SUPERNUS PHARMACEUTICALS | SUPN | 0.52% | $8.0M | 195,813 | -55.0 | $2.4B | Healthcare |
| 25 | PRESTIGE CONSUMER HEALTHCARE | PBH | 0.49% | $7.6M | 159,637 | 13.6 | $2.3B | Healthcare |
| 26 | PERRIGO PLC | PRGO | 0.48% | $7.5M | 467,720 | -1.3 | $2.2B | Healthcare |
| 27 | XERIS BIOPHARMA HOLDINGS | XERS | 0.41% | $6.4M | 614,832 | -110.7 | $2.0B | Healthcare |
| 28 | HARMONY BIOSCIENCES HLDG | HRMY | 0.41% | $6.3M | 166,820 | 12.3 | $2.2B | Healthcare |
| 29 | TREVI THERAPEUTICS | TRVI | 0.35% | $5.4M | 403,470 | -40.9 | $2.0B | Healthcare |
| 30 | MBX BIOSCIENCES | MBX | 0.34% | $5.3M | 100,650 | -22.7 | $2.6B | Healthcare |
| 31 | INNOVIVA | INVA | 0.33% | $5.1M | 243,450 | 4.4 | $1.5B | Healthcare |
| 32 | PACIRA BIOSCIENCES | PCRX | 0.31% | $4.9M | 134,037 | 103.4 | $1.5B | Healthcare |
| 33 | ANI PHARMACEUTICALS | ANIP | 0.31% | $4.8M | 67,941 | 15.1 | $1.7B | Healthcare |
| 34 | OMEROS | OMER | 0.27% | $4.3M | 243,427 | 9.9 | $1.4B | Healthcare |
| 35 | OCULAR THERAPEUTIX | OCUL | 0.27% | $4.2M | 621,867 | -5.1 | $1.6B | Healthcare |
| 36 | NUVATION BIO CLASS A | NUVB | 0.26% | $4.0M | 888,060 | -11.0 | $1.7B | Healthcare |
| 37 | MAZE THERAPEUTICS | MAZE | 0.25% | $3.9M | 123,282 | -11.7 | $1.8B | Healthcare |
| 38 | SEPTERNA | SEPN | 0.23% | $3.5M | 80,197 | -83.8 | $2.1B | Healthcare |
| 39 | LB PHARMACEUTICALS INC | LBRX | 0.22% | $3.4M | 84,802 | -13.5 | $1.3B | Healthcare |
| 40 | RAPPORT THERAPEUTICS | RAPP | 0.21% | $3.3M | 118,156 | -8.0 | $1.2B | Healthcare |
| 41 | HARROW | HROW | 0.20% | $3.1M | 107,155 | -30.2 | $1.1B | Healthcare |
| 42 | PHIBRO ANIMAL HEALTH CORP CLASS A | PAHC | 0.18% | $2.7M | 70,852 | 15.8 | $1.6B | Healthcare |
| 43 | AMPHASTAR PHARMACEUTICALS | AMPH | 0.17% | $2.7M | 105,846 | 15.5 | $1.1B | Healthcare |
| 44 | COLLEGIUM PHARMACEUTICAL | COLL | 0.16% | $2.5M | 109,473 | 15.7 | $782M | Healthcare |
| 45 | ALUMIS | ALMS | 0.13% | $2.0M | 304,661 | -1.8 | $892M | Healthcare |
| 46 | CORMEDIX | CRMD | 0.11% | $1.8M | 222,774 | 3.2 | $595M | Healthcare |
| 47 | WAVE LIFE SCIENCES | WVE | 0.11% | $1.7M | 503,570 | -3.4 | $716M | Healthcare |
| 48 | AVALYN PHARMA INC | AVLN | 0.10% | $1.5M | 59,625 | — | $1.1B | Healthcare |
| 49 | ARVINAS | ARVN | 0.10% | $1.5M | 202,289 | 41.6 | $510M | Healthcare |
| 50 | EVOLUS INC | EOLS | 0.09% | $1.5M | 197,670 | -14.5 | $497M | Healthcare |